Macro Briefing: 13 October 2020
Altimmune's COVID-19 Vaccine Shows Positive Results; Street Sees 289% Upside
New CEO Mortazavi takes UK biotech e-therapeutics into gene silencing
Williams-Sonoma Hikes Dividend By 10%, Resumes Share Buyback Plan
New Oriental Rises On Solid Earnings Beat Despite Covid-Headwinds
Johnson & Johnson Covid-19 Vaccine Trial Halted
USD can’t profit from rising US yields – next leg down ahead?
The Illusion Of Safety: UK Commuter Trains Will Leave Windows Open In Winter To Fight COVID-19
No, Europe! More Debt Is Not The Answer
Sorrento Adds Stem Cell Treatment To Covid-19 Pipeline; Shares Rise
New U.S. Covid-19 cases rise 11% last week, Midwest hard hit
Takeda group begins manufacturing Covid-19 plasma treatment ahead of approval
Crayfish ‘trapping’ fails to control invasive species
Sonoco To Sell Its Contract Packaging Operations For $120M
Coty vs Estée Lauder: Which Beauty Stock Is A Better Buy Amid The Pandemic?
PerkinElmer Raises 3Q Sales Outlook Fueled By COVID-19 Testing Demand
Don't Let The Media Win This Election
Dollar Collapse Is The Biggest Risk – Nassim Taleb
Monetary Distortions Of GDP In 2021
'Optics Look Bad': Top Generals Still Quarantined As US Repeatedly Assures Of 'Military Readiness'
White House Doctor Says Trump Tested Negative For Covid, "Is Not Infectious To Others"
Covid-19 antibodies last at least three months; so do symptoms for many
Age does not contribute to COVID-19 susceptibility
With thousands of subscribers, The Juggernaut raises $2 million for South Asian-focused news outlet
Q3 Earnings Preview: It's The FAAMGs Vs Everyone Else
NYC Issues Over $150,000 In Fines During First Weekend Of New Lockdown
Tips For Facing A Leaner Job Market In Today’s Economy
Dow Jones (INDEXDJX: .DJI) surges, led by Apple, big tech
BSE Sensex ended higher after tech offset bank stocks
Why males may have a worse response to COVID-19